Acrivon Therapeutics (ACRV) Earnings Date, Estimates & Call Transcripts → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free ACRV Stock Alerts $9.82 +0.31 (+3.26%) (As of 04/23/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 14EstimatedActual EPS (Mar. 28) -$0.86 Missed By -$0.14 Consensus EPS (Mar. 28) -$0.72 Get Acrivon Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for ACRV and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueACRV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ACRV Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Acrivon Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.89)($0.89)($0.89)Q2 20241($0.58)($0.58)($0.58)Q3 20241($0.57)($0.57)($0.57)Q4 20241($0.59)($0.59)($0.59)FY 20244($2.63)($2.63)($2.63)ACRV Earnings Date and InformationAcrivon Therapeutics last announced its quarterly earnings results on March 28th, 2024. The reported ($0.86) EPS for the quarter, missing analysts' consensus estimates of ($0.72) by $0.14. Acrivon Therapeutics has generated ($2.73) earnings per share over the last year (($2.73) diluted earnings per share). Earnings for Acrivon Therapeutics are expected to grow in the coming year, from ($3.42) to ($3.36) per share. Acrivon Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.Read More Acrivon Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/14/2024Estimated)------- 3/28/2024Q4 2023($0.72)($0.86)($0.14)($0.86)--11/9/2023Q3 2023($0.72)($0.66)+$0.06($0.66)--8/11/2023Q2 2023($0.65)($0.63)+$0.02($0.63)--5/9/2023Q1 2023($0.64)($0.58)+$0.06($0.58)--3/28/2023Q4 2022($1.10)($0.80)+$0.30($0.80)--12/15/2022Q3 2022($2.44)($5.17)($2.73)($5.17)-- Get the Latest News and Ratings for ACRV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Acrivon Therapeutics Earnings - Frequently Asked Questions When is Acrivon Therapeutics's earnings date? Acrivon Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on ACRV's earnings history. Did Acrivon Therapeutics beat their earnings estimates last quarter? In the previous quarter, Acrivon Therapeutics (NASDAQ:ACRV) missed the analysts' consensus estimate of ($0.72) by $0.14 with a reported earnings per share (EPS) of ($0.86). Learn more on analysts' earnings estimate vs. ACRV's actual earnings. How much profit does Acrivon Therapeutics generate each year? Acrivon Therapeutics (NASDAQ:ACRV) has a recorded net income of -$60.39 million. ACRV has generated -$2.73 earnings per share over the last four quarters. What is Acrivon Therapeutics's EPS forecast for next year? Acrivon Therapeutics's earnings are expected to grow from ($3.42) per share to ($3.36) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Merrimack Pharmaceuticals Earnings Results Theseus Pharmaceuticals Earnings Results ProQR Therapeutics Earnings Results Syros Pharmaceuticals Earnings Results NGM Biopharmaceuticals Earnings Results Vistagen Therapeutics Earnings Results Kinnate Biopharma Earnings Results Assembly Biosciences Earnings Results vTv Therapeutics Earnings Results Solid Biosciences Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NASDAQ:ACRV) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acrivon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
